The significance of melatonin as one of the signaling substrates in the expression of psychopathological disorders in the late period after traumatic brain injury

Authors

DOI:

https://doi.org/10.14739/2310-1210.2024.3.299500

Keywords:

traumatic brain injury, consequences, melatonin, neurological pathophysiology

Abstract

Aim. To discuss the functional properties of melatonin which plays a key role in the expression of psychopathological disorders following traumatic brain injury (TBI).

The influence of melatonin on neurochemical changes, which may lead to various mental disorders, has been analyzed. Specifically, its impact on asthenia, cognitive impairments, emotional instability, and insomnia, which are among the main symptoms accompanying TBI in the chronic phase, has been examined. The importance of studies on melatonin as a neurotransmitter and its role in the circadian rhythm regulation, which is often impaired as a consequence of TBI, has been emphasized. The mechanisms underlying these disorders may be related to dysfunction of the hypothalamus and interhemispheric interactions. Melatonin may influence the recovery processes after TBI, reducing inflammation and providing optimal conditions for tissue regeneration. It opens up new possibilities for the development of therapy aimed at reducing the impact of trauma consequences on patients. Earlier studies have also indicated the option of using melatonin as an antioxidant, which can protect brain tissue from further damage caused by recovery processes after injury.

Studies on pharmacological modulation of the melatonin system could be useful for developing new methods for treatment and prevention of mental disorders associated with TBI. Examining the action of melatonin receptor antagonists and agonists can help to choose optimal treatment strategies aimed at correcting disorders arising as a result of trauma. It holds promise for faster and more complete recovery of mental health in TBI patients.

Conclusions. Considering the significance of melatonin in regulation of physiological processes, further studies may enrich understanding of its role, ensuring the development of more effective treatment methods. Given the safe profile of melatonin and its availability as a supplement, supportive studies in this direction have the potential to positively impact clinical practice.

Author Biographies

M. O. Ovcharenko, State Establishment “Lugansk State Medical University”, Rivne, Ukraine

MD, PhD, DSc, Professor, Head of the Department of Neurology, Psychiatry, Narcology, Ophthalmology, Otolaryngology and Oncology

Ye. Yu. Verbytskyi, State Establishment “Lugansk State Medical University”, Rivne, Ukraine

MD, PhD, Assistant of the Department of Neurology, Psychiatry, Narcology, Ophthalmology, Otolaryngology and Oncology

T. M. Radchenko, Kharkiv National Medical University, Ukraine

MD, PhD, Assistant of the Department of Psychiatry, Narcology, Medical Psychology and Social Work

V. Ye. Kazakov, State Establishment “Lugansk State Medical University”, Rivne, Ukraine

MD, PhD, DSc, Associate Professor of the Department of Neurology, Psychiatry, Narcology, Ophthalmology, Otolaryngology and Oncology

I. O. Chumakova, State Establishment “Lugansk State Medical University”, Rivne, Ukraine

MD, Assistant of the Department of Neurology, Psychiatry, Narcology, Ophthalmology, Otolaryngology and Oncology

References

  1. Ngatuvai M, Martinez B, Sauder M, Beeton G, Andrade R, Maka P, et al. Traumatic Brain Injury, Electrolyte Levels, and Associated Outcomes: A Systematic Review. J Surg Res. 2023;289:106-15. doi: https://doi.org/10.1016/j.jss.2023.03.029
  2. Lucke-Wold BP, Smith KE, Nguyen L, Turner RC, Logsdon AF, Jackson GJ, et al. Sleep disruption and the sequelae associated with traumatic brain injury. Neurosci Biobehav Rev. 2015;55:68-77. doi: https://doi.org/10.1016/j.neubiorev.2015.04.010
  3. Farinde A. An examination of co-occurring conditions and management of psychotropic medication use in soldiers with traumatic brain injury. J Trauma Nurs. 2014;21(4):153-7; quiz 158-9. doi: https://doi.org/10.1097/JTN.0000000000000058
  4. Tateno A, Sakayori T, Takizawa Y, Yamamoto K, Minagawa K, Okubo Y. A case of Alzheimer's disease following mild traumatic brain injury. Gen Hosp Psychiatry. 2015;37(1):97.e7-9. doi: https://doi.org/10.1016/j.genhosppsych.2014.09.016
  5. Bailey NW, Hoy KE, Maller JJ, Segrave RA, Thomson R, Williams N, et al. An exploratory analysis of Go/Nogo event-related potentials in major depression and depression following traumatic brain injury. Psychiatry Res. 2014;224(3):324-34. doi: https://doi.org/10.1016/j.pscychresns.2014.09.008
  6. Aoun R, Rawal H, Attarian H, Sahni A. Impact of traumatic brain injury on sleep: an overview. Nat Sci Sleep. 2019;11:131-40. doi: https://doi.org/10.2147/NSS.S182158
  7. Bell A, Hewins B, Bishop C, Fortin A, Wang J, Creamer JL, et al. Traumatic Brain Injury, Sleep, and Melatonin-Intrinsic Changes with Therapeutic Potential. Clocks Sleep. 2023;5(2):177-203. doi: https://doi.org/10.3390/clockssleep5020016
  8. Zhao D, Wang H, Chen S, Yu D, Reiter RJ. Phytomelatonin: An Emerging Regulator of Plant Biotic Stress Resistance. Trends Plant Sci. 2021;26(1):70-82. doi: https://doi.org/10.1016/j.tplants.2020.08.009
  9. Repova K, Baka T, Krajcirovicova K, Stanko P, Aziriova S, Reiter RJ, et al. Melatonin as a Potential Approach to Anxiety Treatment. Int J Mol Sci. 2022;23(24):16187. doi: https://doi.org/10.3390/ijms232416187
  10. Novais AA, Chuffa LG, Zuccari DA, Reiter RJ. Exosomes and Melatonin: Where Their Destinies Intersect. Front Immunol. 2021;12:692022. doi: https://doi.org/10.3389/fimmu.2021.692022
  11. Zhao ZM, Mei S, Zheng QY, Wang J, Yin YR, Zhang JJ, et al. Melatonin or vitamin C attenuates lead acetate-induced testicular oxidative and inflammatory damage in mice by inhibiting oxidative stress mediated NF-κB signaling. Ecotoxicol Environ Saf. 2023;264:115481. doi: https://doi.org/10.1016/j.ecoenv.2023.115481
  12. Rehman SU, Ikram M, Ullah N, Alam SI, Park HY, Badshah H, et al. Neurological Enhancement Effects of Melatonin against Brain Injury-Induced Oxidative Stress, Neuroinflammation, and Neurodegeneration via AMPK/CREB Signaling. Cells. 2019;8(7):760. doi: https://doi.org/10.3390/cells8070760
  13. Cornelius C, Crupi R, Calabrese V, Graziano A, Milone P, Pennisi G, et al. Traumatic brain injury: oxidative stress and neuroprotection. Antioxid Redox Signal. 2013;19(8):836-53. doi: https://doi.org/10.1089/ars.2012.4981
  14. Carretero M, Escames G, López LC, Venegas C, Dayoub JC, García L, et al. Long-term melatonin administration protects brain mitochondria from aging. J Pineal Res. 2009;47(2):192-200. doi: https://doi.org/10.1111/j.1600-079X.2009.00700.x
  15. Toklu HZ, Hakan T, Biber N, Solakoğlu S, Oğünç AV, Sener G. The protective effect of alpha lipoic acid against traumatic brain injury in rats. Free Radic Res. 2009;43(7):658-67. doi: https://doi.org/10.1080/10715760902988843
  16. Maghool F, Khaksari M, Siahposht Khachki A. Differences in brain edema and intracranial pressure following traumatic brain injury across the estrous cycle: involvement of female sex steroid hormones. Brain Res. 2013;1497:61-72. doi: https://doi.org/10.1016/j.brainres.2012.12.014
  17. Wang Z, Zhou F, Dou Y, Tian X, Liu C, Li H, et al. Melatonin Alleviates Intracerebral Hemorrhage-Induced Secondary Brain Injury in Rats via Suppressing Apoptosis, Inflammation, Oxidative Stress, DNA Damage, and Mitochondria Injury. Transl Stroke Res. 2018;9(1):74-91. doi: https://doi.org/10.1007/s12975-017-0559-x
  18. Reiter RJ, Tan DX, Rosales-Corral S, Galano A, Zhou XJ, Xu B. Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions. Molecules. 2018;23(2):509. doi: https://doi.org/10.3390/molecules23020509
  19. Alluri H, Wilson RL, Anasooya Shaji C, Wiggins-Dohlvik K, Patel S, Liu Y, et al. Melatonin Preserves Blood-Brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition. PLoS One. 2016;11(5):e0154427. doi: https://doi.org/10.1371/journal.pone.0154427
  20. Naseem M, Parvez S. Role of melatonin in traumatic brain injury and spinal cord injury. ScientificWorldJournal. 2014;2014:586270. doi: https://doi.org/10.1155/2014/586270
  21. Wu C, Du M, Yu R, Cheng Y, Wu B, Fu J, et al. A novel mechanism linking ferroptosis and endoplasmic reticulum stress via the circPtpn14/miR-351-5p/5-LOX signaling in melatonin-mediated treatment of traumatic brain injury. Free Radic Biol Med. 2022;178:271-94. doi: https://doi.org/10.1016/j.freeradbiomed.2021.12.007
  22. Carrillo-Vico A, Lardone PJ, Alvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero JM. Melatonin: buffering the immune system. Int J Mol Sci. 2013;14(4):8638-83. doi: https://doi.org/10.3390/ijms14048638
  23. Ali T, Rahman SU, Hao Q, Li W, Liu Z, Ali Shah F, et al. Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation. J Pineal Res. 2020;69(2):e12667. doi: https://doi.org/10.1111/jpi.12667
  24. Wang J, Jiang C, Zhang K, Lan X, Chen X, Zang W, et al. Melatonin receptor activation provides cerebral protection after traumatic brain injury by mitigating oxidative stress and inflammation via the Nrf2 signaling pathway. Free Radic Biol Med. 2019;131:345-55. doi: Role of melatonin in traumatic brain injury and spinal cord injury https://doi.org/10.1016/j.freeradbiomed.2018.12.014
  25. Blum B, Kaushal S, Khan S, Kim JH, Alvarez Villalba CL. Melatonin in Traumatic Brain Injury and Cognition. Cureus. 2021;13(9):e17776. doi: https://doi.org/10.7759/cureus.17776
  26. Xu Z, Zhang F, Xu H, Yang F, Zhou G, Tong M, et al. Melatonin affects hypoxia-inducible factor 1α and ameliorates delayed brain injury following subarachnoid hemorrhage via H19/miR-675/HIF1A/TLR4. Bioengineered. 2022;13(2):4235-47. doi: https://doi.org/10.1080/21655979.2022.2027175
  27. Cao R, Li L, Zhang W, Lu J, Wang Y, Chen Q, et al. Melatonin attenuates repeated mild traumatic brain injury-induced cognitive deficits by inhibiting astrocyte reactivation. Biochem Biophys Res Commun. 2021;580:20-7. doi: https://doi.org/10.1016/ j.bbrc.2021.09.025
  28. Cassimatis M, Browne G, Orr R. The Utility of Melatonin for the Treatment of Sleep Disturbance After Traumatic Brain Injury: A Scoping Review. Arch Phys Med Rehabil. 2023;104(2):340-9. doi: https://doi.org/10.1016/ j.apmr.2022.09.018
  29. Grima NA, Rajaratnam SM, Mansfield D, McKenzie D, Ponsford JL. Poorer sleep quality predicts melatonin response in patients with traumatic brain injury: findings from a randomized controlled trial. J Clin Sleep Med. 2021;17(8):1545-51. doi: https://doi.org/10.5664/jcsm.9234
  30. Lorente L, Martín MM, Ruiz C, Abreu-González P, Ramos-Gómez L, Argueso M, et al. Serum melatonin levels in predicting mortality in patients with severe traumatic brain injury. Anaesth Crit Care Pain Med. 2021;40(6):100966. doi: https://doi.org/10.1016/j.accpm.2021.100966

Downloads

Published

2024-05-31

How to Cite

1.
Ovcharenko MO, Verbytskyi YY, Radchenko TM, Kazakov VY, Chumakova IO. The significance of melatonin as one of the signaling substrates in the expression of psychopathological disorders in the late period after traumatic brain injury. Zaporozhye Medical Journal [Internet]. 2024May31 [cited 2026May21];26(3):242-6. Available from: https://zmj.zsmu.edu.ua/article/view/299500

Issue

Vol. 26 No. 3 (2024)

Section

Review

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons